Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer
Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer
Recruiting · NCT05360277 · Registry updated 2023-12-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer | Metastatic Colorectal Cancer，NED | Recruiting | Phase 2 | 2023-12-12 | NCT05360277 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Yanhong Deng | 7 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Gastrointestinal Hospital, Sun Yat-sen University | Guangzhou | China | 5 |